tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

CareDx upgraded to Buy from Hold at Nephron Research

Nephron Research analyst Thomas DeBourcy upgraded CareDx (CDNA) to Buy from Hold with a $28 price target

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1